The rationale behind using asparaginase agents as an anti-cancer treatment is that normal lymphocytes have the asparagine synthetase enzyme and can promote the biosynthesis of their own asparagine, whereas this does not occur in lymphoma cells [25]. Here, ASNS is linked to cancer.